AFP and hepatocellular carcinoma: Given that carbohydrate antigen 19-9 (CA19-9) and alpha-fetoprotein (AFP) are two well-known serum biomarkers for PDAC and HCC, respectively, we next evaluated whether circulating K102-Env levels correlate with these biomarkers in patients with PDAC and HCC.